School of Medicine

A new study from the School of Medicine shows that a kind of E. coli most associated with “travelers’ diarrhea” and children in underdeveloped areas of the world causes more severe disease in people with blood type A. The findings could lead to a vaccine that could potentially protect people with type A blood against the deadliest effects.

Donate gently used shoes at collection spots on the Medical Campus by May 31. The Office of Sustainability and the School of Medicine Operations and Facilities Management Department is coordinating the effort with  Shoeman Water Projects. The nonprofit helps raise funds to provide clean water in developing countries.

School of Medicine researchers have identified the molecular handle that the chikungunya virus grabs to get inside cells. The findings could lead to ways to prevent or treat disease caused by chikungunya and related viruses.

The Mahoney Institute for Neurosciences (MINS) at the University of Pennsylvania announced that Michael R. Bruchasis is the recipient of the inaugural Rising Star Award in neuroscience research. Bruchas is the Henry E. Mallinckrodt Professor in the departments of anesthesiology and neuroscience at Washington University School of Medicine in St. Louis.

Robert M. Feibel, MD, professor of clinical ophthalmology and visual sciences and director of the Center for History of Medicine at Washington University School of Medicine in St. Louis, recently was selected to present the 28th Snyder Lecture at the 31st annual meeting of the Cogan Ophthalmic History Society.

Robert W. Gereau IV, the Dr. Seymour and Rose T. Brown Professor of Anesthesiology at Washington University School of Medicine in St. Louis, is one of 12 pain experts selected for the 2018-19 Mayday Pain & Society Fellowship.

Suresh Vedantham, MD, professor of radiology at Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, and a team of clinical trial investigators have been recognized with a 2018 Top 10 Clinical Research Achievement Award from the Clinical Research Forum.

A $5 million grant will support research at the School of Medicine aimed at improving breast cancer therapies. The research focuses on HER2-positive breast cancer. Ron Bose, MD, PhD, and Cynthia X. Ma, MD, PhD, are leading the effort.

Researchers at the School of Medicine have discovered, in mice, why a touch can cause such severe itching and, in the process, identified some possible therapeutic targets.

Jim Goodwin, associate director of strategic communication at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, has been named chair of the Public Affairs & Marketing Network, a group of communications and marketing professionals at 70 U.S. cancer centers.